Visión generalGráficoNoticiasTraderScreen

HSBC Aktienanleihe MOR 25.10.2024/  DE000HS3RRE4  /

Frankfurt Zert./HSBC
14/05/2024  12:00:14 Diferencia+0.880 Bid13:34:32 Ask- Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
102.290EUR +0.87% 101.920
Volumen de oferta: 100,000		 -
Tamaño/ Volumen/ Formato de Ask: -		 MORPHOSYS AG O.N. 30.00 EUR 25/10/2024 Call
GlobeNewswire 13:57 ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Conventio...
GlobeNewswire 13:56 VelocityEHS Earns 5 AI Patents and Publishes in Nature
GlobeNewswire 13:55 IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire 13:45 Global Technologies, Ltd. Announces Its Financial Results for the Quarter Ended March 31, 2024 and t...
Newsfile Corp 13:44 Appia Announces Encouraging Initial Results from the Newly Identified Taygeta and Merope Exploration...
TeleTrader 13:42 Turkey to file application to join case against Israel at ICJ
GlobeNewswire 13:35 Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
TeleTrader 13:32 GameStop skyrockets 120% as meme stock rally goes on
TeleTrader 13:30 China outraged over higher US tariffs
GlobeNewswire 13:30 Kroma Announces Spectrum’s Launch Alongside Expansion Plans
GlobeNewswire 13:30 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire 13:30 MiNK Reports First Quarter 2024 Results
GlobeNewswire 13:30 Alimera Sciences Reports First Quarter 2024 Results
GlobeNewswire 13:30 Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enable...
GlobeNewswire 13:30 ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic Process
GlobeNewswire 13:30 Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...
GlobeNewswire 13:30 Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire 13:30 Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire 13:30 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire 13:30 FitLife Brands Announces First Quarter 2024 Results
GlobeNewswire 13:30 BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire 13:30 Batteh Named Saia’s Chief Financial Officer
GlobeNewswire 13:30 XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
GlobeNewswire 13:30 Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire 13:30 Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ